en

PRODUCT DETAIL

Daruph 63 mg

Code 2454E
MA number 44/0291/22-S
Product Form: tbl flm 30x63 mg (blis.OPA/Al/PVC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EA BCR-ABL tyrosine kinase inhibitors
L01EA02 Dasatinib
Shelf life: 36
Container: blister OPA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(3) hybrid application
MA issued: 01.12.2022
Validity: 01.12.2027
Pediatric indication: Yes
Pediatric posology: Yes
Safety feature Yes
Data update: 08.12.2022
eu-flag.png sk-flag.png